Literature DB >> 17072829

Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae).

Monica Rosa Loizzo1, Ataa Said, Rosa Tundis, Khaled Rashed, Giancarlo Antonio Statti, Antje Hufner, Francesco Menichini.   

Abstract

In our screening program for antihypertensive properties of plants, the leaves of Ailanthus excelsa (Roxb), a plant used in Egyptian traditional medicine, were analysed. Chromatographic separation of A. excelsa MeOH extract yielded six flavonoids for the first time from this species, namely apigenin, luteolin, kaempferol-3-O-alpha-arabinopyranoside, kaempferol-3-O-beta-galactopyranoside, quercetin-3-O-alpha-arabinopyranoside and luteolin-7-O-beta-glucopyranoside. The in vitro hypotensive activities of the MeOH extract and the isolated compounds were elucidated. All the flavonoids tested exhibited ACE inhibitory activity, in particular the most active compound was kaempferol-3-O-beta-galactopyranoside with an IC(50) value of 260 microm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17072829     DOI: 10.1002/ptr.2008

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  37 in total

1.  Kinetics of the inhibition of renin and angiotensin i converting enzyme by polar and non-polar polyphenolic extracts of Vernonia amygdalina and Gongronema latifolium leaves.

Authors:  Comfort F Ajibola; Afolabi F Eleyinmi; Rotimi E Aluko
Journal:  Plant Foods Hum Nutr       Date:  2011-11       Impact factor: 3.921

2.  Screening of antibacterial potentials of some medicinal plants from Melghat forest in India.

Authors:  D H Tambekar; B S Khante; B R Chandak; A S Titare; S S Boralkar; S N Aghadte
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-05-07

3.  Inhibition of angiotensin-converting enzyme by aqueous extract of tomato.

Authors:  Dipankar Biswas; Md Main Uddin; Lili L Dizdarevic; Aud Jørgensen; Asim K Duttaroy
Journal:  Eur J Nutr       Date:  2014-02-27       Impact factor: 5.614

4.  Effects of taxifolin on the activity of angiotensin-converting enzyme and reactive oxygen and nitrogen species in the aorta of aging rats and rats treated with the nitric oxide synthase inhibitor and dexamethasone.

Authors:  Tamara V Arutyunyan; Antonina F Korystova; Ludmila N Kublik; Maria Kh Levitman; Vera V Shaposhnikova; Yuri N Korystov
Journal:  Age (Dordr)       Date:  2012-12-28

5.  Apigenin, a plant-derived flavone, activates transient receptor potential vanilloid 4 cation channel.

Authors:  Xin Ma; Dongxu He; Xiaochen Ru; Yun Chen; Yanfei Cai; Iain C Bruce; Qiang Xia; Xiaoqiang Yao; Jian Jin
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Supercritical CO2 extraction of functional compounds from Spirulina and their biological activity.

Authors:  Mallikarjun Gouda K G; Udaya Sankar K; Sarada R; Ravishankar G A
Journal:  J Food Sci Technol       Date:  2014-06-06       Impact factor: 2.701

Review 7.  Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms.

Authors:  Abigail J Larson; J David Symons; Thunder Jalili
Journal:  Adv Nutr       Date:  2012-01-05       Impact factor: 8.701

8.  Salubrious effects of ulinastatin and quercetin alone or in combination in endothelial dysfunction and vascular dementia.

Authors:  Poonam Sharma; Nikita Gaur; Shalini Jayant; B M Sharma; Bhagwat Singh; Harsha Kharkwal; Bhupesh Sharma
Journal:  Pharmacol Rep       Date:  2022-04-09       Impact factor: 3.024

9.  Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies.

Authors:  Ligia Guerrero; Julián Castillo; Mar Quiñones; Santiago Garcia-Vallvé; Lluis Arola; Gerard Pujadas; Begoña Muguerza
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  VPPIPP and IPPVPP: two hexapeptides innovated to exert antihypertensive activity.

Authors:  Fengyun Ding; Bingjun Qian; Xin Zhao; Shanqi Shen; Yun Deng; Danfeng Wang; Feng Zhang; Zhongquan Sui; Pu Jing
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.